SKI Market

Indian Indices

Sensex

84,838.78 -224.56
( -0.26%)

Global Indices

Nasdaq

49,481.66 483.47
(0.99%)

Dow Jones

6,965.42 42.37
(0.61%)

Hang Seng

52,499.37 666.57
(1.29%)

Nikkei 225

10,156.61 152.04
(1.52%)

Forex

USD-INR

90.21 0.17
(0.19%)

EUR-INR

105.52 0.01
(0.01%)

GBP-INR

121.54 0.38
(0.31%)

JPY-INR

0.58 0.00
(0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.78

123617.27

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

cipla ltd

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

84,838.78 -224.56 ( -0.26%)

49,481.66 483.47 (0.99%)

6,965.42 42.37 (0.61%)

52,499.37 666.57 (1.29%)

10,156.61 152.04 (1.52%)

90.21 0.17 (0.19%)

105.52 0.01 (0.01%)

121.54 0.38 (0.31%)

0.58 0.00 (0.26%)